Nektar Therapeutics

Stock Chart, Company Information, and Scan Results

$76.99(as of Apr 2, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Nektar Therapeutics Company Information, Fundamentals, and Technical Indicators

Stock Price$76.99
Ticker SymbolNKTR
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees63
CountyUSA
Market Cap$2,208.7M
EBIDTA-129.7M
10-Day Moving Average72.11
P/E Ratio-9.52
20-Day Moving Average72.26
Forward P/E Ratio34.01
50-Day Moving Average62.26
Earnings per Share-9.73
200-Day Moving Average47.48
Profit Margin-165.45%
RSI61.17
Shares Outstanding28.7M
ATR4.92
52-Week High78.81
Volume552,700
52-Week Low6.48
Most Recent Support Level64.10
Book Value89.8M
Most Recent Resistance Level78.81
P/B Ratio17.40
Upper Keltner83.33
P/S Ratio28.29
Lower Keltner61.20
Debt-to-Equity Ratio83.33
Next Earnings DateUnknown
Cash Surplus-38.4M
Next Ex-Dividend DateUnknown

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.

Nektar Therapeutics In Our Stock Scanner

As of Apr 02, 2026
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.